Xueping Qiu1, Bo Hu2, Yifang Huang3, Yunte Deng4, Xuebin Wang5, Fang Zheng6. 1. Center for Gene Diagnosis, Zhongnan Hospital of Wuhan University, Donghu Rd 169, Wuchang District, Wuhan, 430071, China. qiuxueping2010@whu.edu.cn. 2. The Third Affiliated Hospital of Sun Yat-sen University, Guanzhou, Guandong, China. hubo304191059@126.com. 3. Center for Gene Diagnosis, Zhongnan Hospital of Wuhan University, Donghu Rd 169, Wuchang District, Wuhan, 430071, China. 0501hyf@163.com. 4. Department of Pathology, Hubei Cancer Hospital, Wuhan, Hubei, China. dengyunte@126.com. 5. Center for Gene Diagnosis, Zhongnan Hospital of Wuhan University, Donghu Rd 169, Wuchang District, Wuhan, 430071, China. xbwang2013@whu.edu.cn. 6. Center for Gene Diagnosis, Zhongnan Hospital of Wuhan University, Donghu Rd 169, Wuchang District, Wuhan, 430071, China. zhengfang@whu.edu.cn.
Abstract
BACKGROUND AND AIM: Aberrant methylation of specific genes is frequent event in hepatocellular carcinoma (HCC). Our present study aims to explore the methylation levels of acid phosphatase locus 1 (ACP1), bone morphogenetic protein 4 (BMP4), and testis-specific protein, Y-encoded-like 5 (TSPYL5) and their potential clinical applications in HCC. METHODS: The methylation levels of ACP1, BMP4 and TSPYL5 were analyzed in 188 HCC tissues, 163 matched adjacent non-tumor tissues, and 29 normal liver tissues using a method of methylation-sensitive restriction enzyme-based quantitative PCR, and their associations with clinicopathological features and prognosis were evaluated. RESULTS: Compared with adjacent non-tumor tissues and normal liver tissues, the methylation levels of ACP1, BMP4, and TSPYL5 were significantly increased in HCC tissues (All p < 0.0001). The methylation of each individual gene could distinguish HCC tissues well from adjacent non-tumor tissues with the area under the receiver operating characteristic curves (AUC) of 0.753, 0.785 and 0.917, respectively. Furthermore, a higher methylation of BMP4 was statistically associated with worse disease-free survival (p = 0.006) and might be an independent unfavorable factor for disease-free survival by univariate and multivariate analysis (p = 0.011, HR 3.431, 95 % CI 1.333-8.833). CONCLUSIONS: Our findings suggest that hypermethylation of ACP1, BMP4, and TSPYL5 are common events in HCC and could be used as potentially detectable biomarkers in HCC tissues. Moreover, BMP4 could be potentially served as a methylated biomarker to predict recurrence and metastasis after hepatectomy for HCC patients. However, their potential clinical application value need to be further clarified.
BACKGROUND AND AIM: Aberrant methylation of specific genes is frequent event in hepatocellular carcinoma (HCC). Our present study aims to explore the methylation levels of acid phosphatase locus 1 (ACP1), bone morphogenetic protein 4 (BMP4), and testis-specific protein, Y-encoded-like 5 (TSPYL5) and their potential clinical applications in HCC. METHODS: The methylation levels of ACP1, BMP4 and TSPYL5 were analyzed in 188 HCC tissues, 163 matched adjacent non-tumor tissues, and 29 normal liver tissues using a method of methylation-sensitive restriction enzyme-based quantitative PCR, and their associations with clinicopathological features and prognosis were evaluated. RESULTS: Compared with adjacent non-tumor tissues and normal liver tissues, the methylation levels of ACP1, BMP4, and TSPYL5 were significantly increased in HCC tissues (All p < 0.0001). The methylation of each individual gene could distinguish HCC tissues well from adjacent non-tumor tissues with the area under the receiver operating characteristic curves (AUC) of 0.753, 0.785 and 0.917, respectively. Furthermore, a higher methylation of BMP4 was statistically associated with worse disease-free survival (p = 0.006) and might be an independent unfavorable factor for disease-free survival by univariate and multivariate analysis (p = 0.011, HR 3.431, 95 % CI 1.333-8.833). CONCLUSIONS: Our findings suggest that hypermethylation of ACP1, BMP4, and TSPYL5 are common events in HCC and could be used as potentially detectable biomarkers in HCC tissues. Moreover, BMP4 could be potentially served as a methylated biomarker to predict recurrence and metastasis after hepatectomy for HCC patients. However, their potential clinical application value need to be further clarified.
Entities:
Keywords:
ACP1; BMP4; DNA methylation; Hepatocellular carcinoma; TSPYL5
Authors: Eun Jin Kim; So Yong Lee; Tae Rim Kim; Soo Im Choi; Eun Wie Cho; Kug Chan Kim; In Gyu Kim Journal: Biochem Biophys Res Commun Date: 2010-01-15 Impact factor: 3.575
Authors: Christopher J Ricketts; Mark R Morris; Dean Gentle; Michael Brown; Naomi Wake; Emma R Woodward; Noel Clarke; Farida Latif; Eamonn R Maher Journal: Epigenetics Date: 2012-03 Impact factor: 4.528
Authors: Enders K O Ng; Candy P H Leung; Vivian Y Shin; Chris L P Wong; Edmond S K Ma; Hong Chuan Jin; Kent-Man Chu; Ava Kwong Journal: PLoS One Date: 2011-07-18 Impact factor: 3.240
Authors: Gabriela Hernandez-Meza; Johann von Felden; Edgar E Gonzalez-Kozlova; Teresa Garcia-Lezana; Judit Peix; Anna Portela; Amanda J Craig; Sergi Sayols; Myron Schwartz; Bojan Losic; Vincenzo Mazzaferro; Manel Esteller; Josep M Llovet; Augusto Villanueva Journal: Hepatology Date: 2021-06-15 Impact factor: 17.298